Targeted Small Airways Therapy in Persistent Asthma
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2019
Price : $35 *
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms ANDA3
- 31 Aug 2018 Biomarkers information updated
- 02 Aug 2018 Status changed from recruiting to completed.
- 20 Apr 2018 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.